Status:
COMPLETED
Voiding Disorders in Children After Sacrococcygeal Teratoma Resection
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Sacrococcygeal Teratoma
Neurogenic Bladder
Eligibility:
All Genders
6-18 years
Brief Summary
Sacrococcygeal teratomas are the most common neonatal tumors and require rapid and complete resection. Tumor nerve compression and pelvic surgical sequelae may lead to many and varied voiding disorder...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Children aged 6 to 18
- history of sacrococcygeal teratoma resection
- Exclusion criteria:
- Associated anorectal malformation
- Associated neurological pathology
Exclusion
Key Trial Info
Start Date :
June 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05182853
Start Date
June 16 2021
End Date
December 1 2021
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Montpellier
Montpellier, France, 34295